Archive for August 2019

FDA Issues Warning Letter to Curaleaf Over Its CBD Products

Last week, the Food and Drug Administration (FDA) sent a regulatory ‘Warning Letter‘ to Curaleaf, Inc. (Curaleaf) regarding its cannabidiol (CBD) containing products. CBD and tetrahydrocannabinol (THC) are two natural compounds found in cannabis or marijuana plants. CBD is a non-psychoactive compound, meaning that it doesn’t produce the high or sense of euphoria associated with…

Read More